IWA
PFE icon

Intercontinental Wealth Advisors’s Pfizer PFE Stock Holding History

Intercontinental Wealth Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		$753K Sell
20,529
-836
-4% -$32.5K 0.18% 126
2023
Q1 		$872K Sell
21,365
-1,215
-5% -$52.5K 0.22% 109
2022
Q4 		$1.16M Sell
22,580
-4,995
-18% -$239K 0.34% 61
2022
Q3 		$1.21M Sell
27,575
-814
-3% -$39.6K 0.38% 57
2022
Q2 		$1.49M Sell
28,389
-774
-3% -$39.4K 0.4% 43
2022
Q1 		$1.51M Sell
29,163
-2,156
-7% -$112K 0.34% 54
2021
Q4 		$1.85M Sell
31,319
-853
-3% -$42.3K 0.39% 38
2021
Q3 		$1.38M Sell
32,172
-2,543
-7% -$113K 0.32% 52
2021
Q2 		$1.36M Buy
34,715
+2,546
+8% +$99K 0.27% 65
2021
Q1 		$1.17M Sell
32,169
-2,401
-7% -$85.2K 0.25% 80
2020
Q4 		$1.27M Buy
34,570
+2,284
+7% +$83.8K 0.31% 62
2020
Q3 		$1.12M Sell
32,286
-4,775
-13% -$167K 0.33% 59
2020
Q2 		$1.15M Sell
37,061
-3,068
-8% -$104K 0.37% 52
2020
Q1 		$1.24M Buy
40,129
+24,568
+158% +$837K 0.66% 31
2019
Q4 		$564K Sell
15,561
-23,858
-61% -$850K 0.47% 43
2019
Q3 		$1.34M Sell
39,419
-961
-2% -$34.9K 0.83% 26
2019
Q2 		$1.66M Sell
40,380
-3,444
-8% -$137K 0.86% 20
2019
Q1 		$1.77M Sell
43,824
-3,824
-8% -$153K 0.88% 21
2018
Q4 		$1.97M Sell
47,648
-1,654
-3% -$68.7K 1.1% 17
2018
Q3 		$2.06M Sell
49,302
-10,956
-18% -$422K 1.03% 22
2018
Q2 		$2.07M Sell
60,258
-12,765
-17% -$436K 1.15% 20
2018
Q1 		$2.46M Sell
73,023
-15,002
-17% -$516K 1.42% 10
2017
Q4 		$3.02M Sell
88,025
-7,923
-8% -$270K 1.7% 11
2017
Q3 		$3.25M Sell
95,948
-3,526
-4% -$113K 1.98% 9
2017
Q2 		$3.17M Sell
99,474
-15,356
-13% -$484K 2.04% 8
2017
Q1 		$3.73M Buy
114,830
+449
+0.4% +$14.2K 2.24% 11
2016
Q4 		$3.52M Buy
114,381
+5,447
+5% +$166K 2.27% 10
2016
Q3 		$3.5M Sell
108,934
-4,393
-4% -$147K 2.5% 11
2016
Q2 		$3.79M Sell
113,327
-6,217
-5% -$198K 2.79% 8
2016
Q1 		$3.36M Sell
119,544
-16,132
-12% -$461K 2.53% 10
2015
Q4 		$4.16M Buy
+135,676
New +$4.27M 2.85% 8

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Intercontinental Wealth Advisors's PFE Position: Q2 2023 in Review

Intercontinental Wealth Advisors reduced its Pfizer (PFE) stake by 3.9% in Q2 2023, selling an estimated $32.5K and leaving 20,529 shares worth $753K. The position accounts for 0.18% of the portfolio, ranked #126.

Intercontinental Wealth Advisors first reported a position in PFE in Q4 2015 and has held it in 31 quarters since. The position peaked at $4.16M in Q4 2015. 3,041 funds tracked by Wall St. Rank hold PFE as of Q2 2023.

  • Intercontinental Wealth Advisors held 20,529 shares of Pfizer worth $753K as of Q2 2023.
  • Intercontinental Wealth Advisors sold 836 Pfizer shares in Q2 2023, an estimated $32.5K.
  • Pfizer made up 0.18% of Intercontinental Wealth Advisors's portfolio in Q2 2023, its #126 holding.
  • Intercontinental Wealth Advisors first reported a position in Pfizer in Q4 2015 and has held it in 31 quarters since.
  • Intercontinental Wealth Advisors's Pfizer position peaked at $4.16M in Q4 2015.
  • 3,041 funds tracked by Wall St. Rank held Pfizer as of Q2 2023.

Based on Intercontinental Wealth Advisors's 13F filing for Q2 2023, filed 21 Jul 2023.